Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2006-04-25
2006-04-25
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S234100, C424S259100, C424S278100
Reexamination Certificate
active
07033591
ABSTRACT:
The invention concerns the use of a membrane fraction of gram-negative bacteria, in particularKlebsiella pnemoniaefor preparing a pharmaceutical composition that is immunostimulant and/or capable of inducing an antitumoral immune response, designed in particular for treating and preventing cancers. The invention further comprises methods for preparing said membrane factions and pharmaceutical compositions containing them, in particular combined with anticancer compounds.
REFERENCES:
patent: 4501693 (1985-02-01), Dussourd d'Hinterland et al.
patent: 5242806 (1993-09-01), Yen-Maguire et al.
patent: 5648478 (1997-07-01), Henderson
patent: 5674739 (1997-10-01), Shyjan
patent: 5776898 (1998-07-01), Teicher et al.
patent: 2596064 (1986-09-01), None
Cheng et al (IEEE Transactions on Medical Imaging, vol. 17, No. 3, pp 442-450, Jun. 1998).
Burton, R.C. 2000. Malignant melanoma in the year 2000. CA Cancer J. Clin. 50:209-213.
Beck Alain
Bonnefoy Jean-Yves
Corvaia Nathalie
Libon Christine
Hueschen and Sage
Navarro Mark
Pierre Fabre Medicament
LandOfFree
Immunostimulant bacterial membrane fractions in cancer... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunostimulant bacterial membrane fractions in cancer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunostimulant bacterial membrane fractions in cancer... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3531600